Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Research diagnoses for tardive dyskinesia.

• Nina Schooler, John M. Kane
• Archives of general psychiatry
• 1982

Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses.

• Matcheri S. Keshavan, Richard A. Sanders, +4 authors Nina Schooler
• The American journal of psychiatry
• 2003

OBJECTIVE Neurological abnormalities are frequently seen in patients with first-episode psychotic disorders but are generally considered to be diagnostically nonspecific, neurologically… (More)

Physical health monitoring of patients with schizophrenia.

• Stephen R Marder, Susan M. Essock, +19 authors Steven P. Shon
• The American journal of psychiatry
• 2004

OBJECTIVE Schizophrenia is associated with several chronic physical illnesses and a shorter life expectancy, compared with life expectancy in the general population. One approach to improving the… (More)

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

• Robert W. Buchanan, D. C. Javitt, +5 authors William T. Carpenter
• The American journal of psychiatry
• 2007

OBJECTIVE Patients with schizophrenia frequently present with negative symptoms and cognitive impairments for which no effective treatments are known. Agents that act at the glycine site of the… (More)

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride.

• Gerard E. Hogarty, Nina Schooler, Richard Ulrich, F Mussare, Paola Ferro, E Herron
• Archives of general psychiatry
• 1979

The ability of long-acting fluphenazine decanoate and oral fluphenazine hydrochloride to forestall relapse among newly discharge schizophrenic patients is examined in the context of high and low… (More)

Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.

• Serge M Sevy, Murray H Rosenthal, +4 authors Nina Schooler
• The Journal of clinical psychiatry
• 2005

OBJECTIVE To assess the effects of modafinil on fatigue, symptoms, attention, working memory, and executive functioning in schizophrenia patients treated with psychotropic medications. METHOD… (More)

Correlates of insight in first episode psychosis

• Matcheri S. Keshavan, Jonathan Rabinowitz, Goedele DeSmedt, Phillip D Harvey, Nina Schooler
• Schizophrenia Research
• 2004

Impaired insight is common in schizophrenia and may be related to poor treatment adherence. Few studies have examined the clinical and neurocognitive correlates of insight in early schizophrenia.… (More)

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

• Terry E. Goldberg, Robert S. Goldman, +7 authors Delbert G Robinson
• Archives of general psychiatry
• 2007

CONTEXT Cognitive impairment in schizophrenia is frequent, involves multiple domains, and is enduring. Numerous recent clinical trials have suggested that second-generation antipsychotic medications… (More)

SAFTEE: a technique for the systematic assessment of side effects in clinical trials.

• Jerome F Levine, Nina Schooler
• Psychopharmacology bulletin
• 1986

Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

• M. S. Keshavan, Gretchen L Haas, +5 authors Jay W. Pettegrew
• Journal of psychiatric research
• 1998

Accumulating evidence suggests alterations in brain structure, especially in the prefrontal and temporal cortex, in schizophrenia. Previous studies examining the progression of brain structural… (More)

• ‹
• 1
• 2
• 3
• 4
• 5
• ›